Servin Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 02-12-2024
- Paid Up Capital ₹ 2.00 M
as on 02-12-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 M
as on 02-12-2024
About Servin Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹8.00 M.
Bhavesh Doshi, Shital Doshi, Prafulbhai Nathwani, and Six other members serve as directors at the Company.
- CIN/LLPIN
U27117GJ1995PTC026220
- Company No.
026220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationRajkot, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Servin Pharma Distributors?
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prafulbhai Nathwani  | Director | 06-Jun-1995 | Current |
| Pankaj Nathwani | Director | 06-Jun-1995 | Current |
Bhavesh Doshi  | Director | 19-Mar-1996 | Current |
| Shital Doshi | Director | 06-Jun-1995 | Current |
| Sarlaben Nagrecha | Director | 19-Mar-1996 | Current |
| Tushar Nagrecha | Director | 06-Jun-1995 | Current |
Financial Performance and Corporate Structure Insights of Servin Pharma Distributors.
Servin Pharma Distributors Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Servin Pharma Distributors?
In 2017, Servin Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Servin Healthcare Private LimitedActive 28 years 7 monthsBhavesh Doshi, Shital Doshi and 7 more are mutual person
- Abhishek Critical Care Unit Private LimitedActive 24 years 9 months
Bhavesh Doshi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citizen Co-Operative Bank Ltd. Creation Date: 26 Sep 1996 | ₹5.00 M | Open |
Citizen Co-Operative Bank Ltd. Creation Date: 26 Sep 1996 | ₹3.00 M | Open |
How Many Employees Work at Servin Pharma Distributors?
Unlock and access historical data on people associated with Servin Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Servin Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Servin Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
